Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
Year: 2014
Type: review
Abstract: Amphotericin B (AmB) is a macrolide polyene antifungal antibiotic (Gallis et al. 1990 ; AbuSalah 1996 ; Hartsel and Bolard 1996 ; Carrillo-Munoz et al. 2006 ; Cereghetti and Carreira 2006 ). The number of research papers published in recent years on its pharmacological properties, clinical therapeutic effects, and toxicity is evidence of the importance of AmB in contemporary medicine (Brajtburg et al. 1990 ; Tiphine et al. 1999 ; Fanos and Cataldi 2000 ; Lemke et al. 2005 ; Fanos et al. 2007 ; Moen et al. 2009 ; Hamill 2013 ). AmB, a metabolite of Streptomyces nodosus , causes disintegration of the fungal lipid membranes. These membranes contain ergosterol, which, similar to cholesterol, changes dynamic properties and stabilizes lipid bilayer structure. AmB has better selectivity for membranes containing ergosterol than for those containing cholesterol. This property enables use of the drug to treat deep fungal infections that occur in the aftermath of AIDS or transplantation. Despite its antifungal activity, AmB has many sides effects which are most probably related to AmB–cholesterol interactions (Wilcock et al. 2013 ). In addition, AmB has several side effects because of formation of aqueous pores (Cohen 1998 ); among these, nephrotoxicity (Fanos and Cataldi 2001 ) and hematotoxicity (Wong-Beringer et al. 1998 ) are the most serious.
Source: European Biophysics Journal
Author: Daniel Michał Kamiński
Institution: University of Life Sciences in Lublin
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,490
OpenAlex ID: W1970934950
